| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |